Keywords: archimedes, announces, positive, ph, results, t3, heart

Archimedes announces positive Ph I results for T3 heart candidate

Article | 16 June 2008

Print This

UK drug development firm Archimedes and USA-based T3 therapeutics have released positive Phase I study data of their oral formulation ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in